BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 34654345)

  • 21. Prognostic value of pretreatment smoking status for small cell lung cancer: A meta-analysis.
    Huang L; Shi Y
    Thorac Cancer; 2020 Nov; 11(11):3252-3259. PubMed ID: 32959954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis.
    Lu Y; Jiang J; Ren C
    PLoS One; 2020; 15(4):e0230979. PubMed ID: 32241019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-therapeutic circulating tumor cell-associated white blood cell clusters predict poor survival in patients with advanced driver gene-negative non-small cell lung cancer.
    Wang Y; Liu Y; Zhang Z; Lu B; Gao Y; Tong L; Hu M; Lin PP; Li B; Zhang T
    BMC Cancer; 2023 Jun; 23(1):578. PubMed ID: 37349714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity of circulating tumor cells (CTCs) in patients with recurrent small cell lung cancer (SCLC) treated with pazopanib.
    Messaritakis I; Politaki E; Plataki M; Karavassilis V; Kentepozidis N; Koinis F; Samantas E; Georgoulias V; Kotsakis A
    Lung Cancer; 2017 Feb; 104():16-23. PubMed ID: 28212995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer.
    Lindsay CR; Blackhall FH; Carmel A; Fernandez-Gutierrez F; Gazzaniga P; Groen HJM; Hiltermann TJN; Krebs MG; Loges S; López-López R; Muinelo-Romay L; Pantel K; Priest L; Riethdorf S; Rossi E; Terstappen L; Wikman H; Soria JC; Farace F; Renehan A; Dive C; Besse B; Michiels S
    Eur J Cancer; 2019 Aug; 117():60-68. PubMed ID: 31254940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups.
    Lindsay CR; Faugeroux V; Michiels S; Pailler E; Facchinetti F; Ou D; Bluthgen MV; Pannet C; Ngo-Camus M; Bescher G; Caramella C; Billiot F; Remon J; Planchard D; Soria JC; Besse B; Farace F
    Ann Oncol; 2017 Jul; 28(7):1523-1531. PubMed ID: 28633480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis.
    Li Y; Wu G; Yang W; Wang X; Duan L; Niu L; Zhang Y; Liu J; Hong L; Fan D
    BMC Cancer; 2020 Jun; 20(1):581. PubMed ID: 32571299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between circulating tumor cells in the peripheral blood and the prognosis of gastric cancer patients: a meta-analysis.
    Jin T; Liang PP; Chen ZH; He FJ; Li ZD; Chen ZW; Hu JK; Yang K
    Ther Adv Med Oncol; 2023; 15():17588359231183678. PubMed ID: 37435560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Circulating Tumor Cells in Predicting Therapeutic Response in Small Cell Lung Cancer Patients.
    Wang X; Ma K; Wang Y; He H; Hu JF; Li W
    Arch Med Res; 2016 Aug; 47(6):454-459. PubMed ID: 27986125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells.
    Su Z; Wang Z; Ni X; Duan J; Gao Y; Zhuo M; Li R; Zhao J; Ma Q; Bai H; Chen H; Wang S; Chen X; An T; Wang Y; Tian Y; Yu J; Wang D; Xie XS; Bai F; Wang J
    Clin Cancer Res; 2019 Aug; 25(16):5049-5060. PubMed ID: 31113842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
    Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
    J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of circulating tumor cells in small--cell lung cancer patients: a meta-analysis.
    Zhang J; Wang HT; Li BG
    Asian Pac J Cancer Prev; 2014; 15(19):8429-33. PubMed ID: 25339041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer.
    Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Xu H; Wang Z
    BMC Cancer; 2015 Mar; 15():202. PubMed ID: 25880692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The detection of circulating tumor cells indicates poor therapeutic efficacy and prognosis in patients with nonsmall cell lung cancer: A systematic review and meta-analysis.
    Wang S; Liu X; Lv H; Yu J; Li H
    J Evid Based Med; 2024 Apr; ():. PubMed ID: 38600712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating tumour cells in patients with lung cancer universally indicate poor prognosis.
    Jin F; Zhu L; Shao J; Yakoub M; Schmitt L; Reißfelder C; Loges S; Benner A; Schölch S
    Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36517047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
    Beck TN; Boumber YA; Aggarwal C; Pei J; Thrash-Bingham C; Fittipaldi P; Vlasenkova R; Rao C; Borghaei H; Cristofanilli M; Mehra R; Serebriiskii I; Alpaugh RK
    BMC Cancer; 2019 Jun; 19(1):603. PubMed ID: 31215484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
    Yang C; Zou K; Zheng L; Xiong B
    BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
    Qin K; Hou H; Liang Y; Zhang X
    BMC Cancer; 2020 Apr; 20(1):328. PubMed ID: 32299384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis.
    Jiang H; Gu X; Zuo Z; Tian G; Liu J
    PLoS One; 2021; 16(7):e0254433. PubMed ID: 34242363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.